液態生物檢體市場：按生物標記類型、檢體類型、疾病、最終用戶和地區分類

Liquid Biopsy Market, By Biomarker Type, By Sample Type, By Disease Indication, By End User, By Geography

出版日期: 2026年04月13日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2026年，液態生物檢體市場規模將達到13.54億美元，2033年將達到73.4億美元。預計從2026年到2033年，其複合年成長率將達到27.5%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	13.54億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	27.50%	2033年市場規模預測：	73.4億美元

液態生物檢體是一種先進的非侵入性癌症診斷技術，它利用血液、腦脊髓液、血漿和尿液等生物體液來檢測癌症。液態生物檢體利用循環核酸、循環性腫瘤細胞（CTC）和外泌體作為癌症診斷的生物標記。預計在預測期內，對非侵入性診斷方法日益成長的需求將推動全球液態生物檢體市場的成長。此外，癌症發生率的上升也是推動全球液態生物檢體市場在預測期內成長的主要因素。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
本研究根據以下參數對全球液態生物檢體市場的主要參與者進行了分析：公司概況、財務績效、產品系列、企業發展區域、分銷策略、關鍵發展和策略以及未來計劃。
透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球液態生物檢體報告針對業內各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太地區的其他國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第9章競爭情勢

公司簡介
- Biocept, Inc.
- Qiagen NV
- Trovagene, Inc.
- Janssen Global Services, LLC
- MDxHealth SA
- Natera, Inc.
- F. Hoffmann-La Roche Ltd
- Silicon Biosystems
- Pathway Genomics Corporation
- Sysmex Corporation

第10章

參考
調查方法

簡介目錄

Product Code: CMI1223

Liquid Biopsy Market is estimated to be valued at USD 1,354.0 Mn in 2026 and is expected to reach USD 7,340.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 27.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,354.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	27.50%	2033 Value Projection:	USD 7,340.0 Mn

Liquid biopsy is an advanced non-invasive cancer diagnostic technique that uses bio-fluids such as blood, cerebrospinal fluid (CSF), plasma, and urine for detecting cancer. Liquid biopsy uses circulating nucleic acids, circulating tumor cells (CTC), and exosomes as biomarkers for diagnosis of cancer. Increasing demand for non-invasive diagnostic procedures is expected to boost growth of the global liquid biopsy market over the forecast period. Furthermore, increasing prevalence of cancer is a major factor propelling growth of the global liquid biopsy market over the forecast period.

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global Liquid Biopsy based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Biocept, Inc., Qiagen N.V., Trovagene, Inc., Janssen Global Services, LLC, MDxHealth SA, Natera, Inc., F. Hoffmann-La Roche Ltd., Silicon Biosystems, Pathway Genomics Corporation, and Sysmex Corporation.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global Liquid Biopsy report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

By Biomarker Type
- CTC (Circulating Tumor Cells)
- ctNA (Circulating Tumor Nucliec Acids)
- Exosomes
By Device Type
- Blood
- Urine
- Others
By Disease Indication
- Lung Cancer
- Prostate Cancer
- Gastrointestinal Cancer
- Breast Cancer
- Colorectal Cancer
- Leukemia
- Others
By End User
- Hospitals
- Cancer Institutes
- Academic Institutes
- Diagnostic Centers
Global Liquid Biopsy Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- Biocept, Inc.
- Qiagen N.V.
- Trovagene, Inc.
- Janssen Global Services
- LLC, MDxHealth SA, Natera, Inc.
- F. Hoffmann-La Roche Ltd.
- Silicon Biosystems
- Pathway Genomics Corporation
- Sysmex Corporation

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Biomarker Type
- Market Snippet, By Sample Type
- Market Snippet, By Disease Indication
- Market Snippet, By End User
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Technological Advancement
Regulatory Scenario

4. Global Liquid Biopsy Market, By Biomarker Type, 2021- 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
CTC (Circulating Tumor Cells)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
ctNA (Circulating Tumor Nucliec Acids)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Exosomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

5. Global Liquid Biopsy Market, By Sample Type, 2021 - 2033 (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Global Liquid Biopsy Market, By Disease Indication 2021- 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Lung Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Gastrointestinal Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Prostate Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Breast Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Colorectal Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Leukemia
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Others
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

7. Global Liquid Biopsy Market, By End User 2021- 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Cancer Institutes
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Academic Institutes
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Diagnostic Centers
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

8. Global Liquid Biopsy Market, By Region, 2021- 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
North America
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of APAC
Middle East
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - South Africa
  - Central Africa
  - North Africa

9. Competitive Landscape

Company Profiles
- Biocept, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Qiagen N.V
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Trovagene, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Janssen Global Services, LLC
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- MDxHealth SA
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Natera, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- F. Hoffmann-La Roche Ltd
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Silicon Biosystems
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pathway Genomics Corporation
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sysmex Corporation
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies